NFAT1 transcription factor is central in the regulation of tissue microenvironment for tumor metastasis
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
19/10/2012
19/10/2012
2011
|
Resumo |
Members of the nuclear factor of activated T cell (NFAT) family of transcription factors were originally described in T lymphocytes but later shown to be expressed in several immune and non-immune cell types. NFAT proteins can modulate cellular transformation intrinsically, and NFAT-deficient (NFAT1-/-) mice are indeed more susceptible to transformation than wild-type counterparts. However, the contribution of an NFAT1-/- microenvironment to tumor progression has not been studied. We have addressed this question by inoculating NFAT1-/- mice with B16F10 melanoma cells intravenously, an established model of tumor homing and growth. Surprisingly, NFAT1-/- animals sustained less tumor growth in the lungs after melanoma inoculation than wild-type counterparts. Even though melanoma cells equally colonize NFAT1-/- and wild-type lungs, tumors do not progress in the absence of NFAT1 expression. A massive mononuclear perivascular infiltrate and reduced expression of TGF-beta in the absence of NFAT1 suggested a role for tumor-infiltrating immune cells and the cytokine milieu. However, these processes are independent of an IL-4-induced regulatory tumor microenvironment, since lack of this cytokine does not alter the phenotype in NFAT1-/- animals. Bone marrow chimera experiments meant to differentiate the contributions of stromal and infiltrating cells to tumor progression demonstrated that NFAT1-induced susceptibility to pulmonary tumor growth depends on NFAT1-expressing parenchyma rather than on bone marrow-derived cells. These results suggest an important role for NFAT1 in radio-resistant tumor-associated parenchyma, which is independent of the anti-tumor immune response and Th1 versus Th2 cytokine milieu established by the cancer cells, but able to promote site-specific tumor growth. CNPq FAPERJ CAPES/FAPERJ CAPES/CNPq |
Identificador |
CANCER IMMUNOLOGY IMMUNOTHERAPY, v.60, n.4, p.537-546, 2011 0340-7004 http://producao.usp.br/handle/BDPI/21876 10.1007/s00262-010-0964-4 |
Idioma(s) |
eng |
Publicador |
SPRINGER |
Relação |
Cancer Immunology Immunotherapy |
Direitos |
restrictedAccess Copyright SPRINGER |
Palavras-Chave | #NFAT #Cancer #Tumor microenvironment #Melanoma B16F10 #ACTIVATED T-CELLS #GENE-EXPRESSION #IFN-GAMMA #INTERFERON-GAMMA #NUCLEAR FACTOR #B16 MELANOMA #MICE LACKING #CANCER #DIFFERENTIATION #PROGRESSION #Oncology #Immunology |
Tipo |
article original article publishedVersion |